Combined cisplatin, doxorubicin, and mitomycin for the treatment of advanced pleural mesothelioma
Open Access
- 15 May 1997
- Vol. 79 (10) , 1897-1902
- https://doi.org/10.1002/(sici)1097-0142(19970515)79:10<1897::aid-cncr9>3.0.co;2-d
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- Activity of doxorubicin and cisplatin combination chemotherapy in patients with diffuse malignant pleural mesothelioma. An italian lung cancer task force (FONICAP) phase II studyCancer, 1991
- Chemotherapy in malignant mesothelioma: a reviewCancer Chemotherapy and Pharmacology, 1991
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experienceCancer, 1983
- Treatment of six cases of mesothelioma with doxorubicin and cisplatinCancer, 1983
- Reporting results of cancer treatmentCancer, 1981
- Malignant MesotheliomaNew England Journal of Medicine, 1980
- Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.Thorax, 1976